Insider Transactions in Q4 2022 at Hologic Inc (HOLX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,649
-16.18%
|
$125,324
$76.4 P/Share
|
|
Dec 05
2022
|
John M. Griffin General Counsel |
SELL
Bona fide gift
|
Direct |
2,989
-1.77%
|
-
|
|
Nov 30
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
33,500
-0.72%
|
$2,512,500
$75.72 P/Share
|
|
Nov 15
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Open market or private sale
|
Direct |
19,118
-13.15%
|
$1,433,850
$75.34 P/Share
|
|
Nov 15
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
12,490
+14.3%
|
$499,600
$40.85 P/Share
|
|
Nov 14
2022
|
John M. Griffin General Counsel |
SELL
Open market or private sale
|
Direct |
26,902
-6.98%
|
$2,044,552
$76.28 P/Share
|
|
Nov 14
2022
|
John M. Griffin General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
26,902
+12.08%
|
$1,076,080
$40.85 P/Share
|
|
Nov 11
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,141
-7.22%
|
$985,575
$75.93 P/Share
|
|
Nov 11
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-2.72%
|
$21,375
$75.93 P/Share
|
|
Nov 11
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-2.6%
|
$18,900
$75.93 P/Share
|
|
Nov 11
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
8,780
-11.29%
|
$658,500
$75.93 P/Share
|
|
Nov 11
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,915
-2.37%
|
$143,625
$75.93 P/Share
|
|
Nov 11
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,145
-11.39%
|
$1,135,875
$75.93 P/Share
|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
96,355
-3.94%
|
$7,226,625
$75.93 P/Share
|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
138,422
-1.84%
|
$10,381,650
$75.72 P/Share
|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,422
+3.62%
|
$2,480,972
$26.21 P/Share
|
|
Nov 11
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-2.22%
|
$24,150
$75.93 P/Share
|
|
Nov 09
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-0.33%
|
$43,848
$72.11 P/Share
|
|
Nov 09
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-1.82%
|
$13,968
$72.11 P/Share
|
|
Nov 09
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-2.03%
|
$14,472
$72.11 P/Share
|
|
Nov 09
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
591
-0.75%
|
$42,552
$72.11 P/Share
|
|
Nov 09
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-0.17%
|
$9,720
$72.11 P/Share
|
|
Nov 09
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.51%
|
$48,960
$72.11 P/Share
|
|
Nov 09
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,776
-0.23%
|
$415,872
$72.11 P/Share
|
|
Nov 09
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-1.21%
|
$9,432
$72.11 P/Share
|
|
Nov 09
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.46%
|
$15,480
$72.11 P/Share
|
|
Nov 08
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.24%
|
$14,162
$73.71 P/Share
|
|
Nov 08
2022
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,724
+7.67%
|
-
|
|
Nov 08
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
688
-0.51%
|
$50,224
$73.71 P/Share
|
|
Nov 08
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,565
+5.33%
|
-
|
|
Nov 08
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,052
-0.16%
|
$295,796
$73.71 P/Share
|
|
Nov 08
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
709
-0.9%
|
$51,757
$73.71 P/Share
|
|
Nov 08
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-1.15%
|
$9,198
$73.71 P/Share
|
|
Nov 08
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-1.38%
|
$15,111
$73.71 P/Share
|
|
Nov 08
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
602
-0.33%
|
$43,946
$73.71 P/Share
|
|
Nov 08
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-2.23%
|
$17,739
$73.71 P/Share
|
|
Nov 08
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-3.15%
|
$23,506
$73.71 P/Share
|
|
Nov 08
2022
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,034
+28.28%
|
-
|
|
Nov 07
2022
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,987
+1.46%
|
-
|
|
Nov 07
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
6,724
+7.84%
|
-
|
|
Nov 07
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
3,362
+23.49%
|
-
|
|
Nov 07
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,176
+7.29%
|
-
|
|
Nov 07
2022
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,052
+3.2%
|
-
|
|
Nov 07
2022
|
Elisabeth A Hellmann SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,353
+17.73%
|
-
|
|
Nov 01
2022
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19,642
+9.98%
|
-
|
|
Nov 01
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
12,277
+14.51%
|
-
|
|
Nov 01
2022
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
10,436
+12.32%
|
-
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,545
-10.29%
|
$1,047,240
$72.5 P/Share
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,545
+5.02%
|
$552,710
$38.8 P/Share
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,872
+14.13%
|
-
|